Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.
Dendrite Clinical Systems and The American Vein and Lymphatic Society (formerly the American College of Phlebology) are delighted to announce the launch of the American Vein and Lymphatic Society Registry - a ‘real-time’ clinical database that will identify practice patterns for venous and lymphatic disease diagnosis and treatment across North America.
The aim of the registry is to analyse the aggregate data and produce an annual publication that will outline important demographic features, risk factors, diagnostic characteristics, disease patterns, and treatment outcomes of venous and lymphatic disease within North America.
It is hoped that the Registry will assist the AVLS in developing standards of care and guideline documents for the treatment of various venous and lymphatic disease by improving the standards of medical practitioners, the quality of patient care and patient management.
The Registry will allow physicians to enter the demographics, risk factors, clinical features, management details and follow-up of all major venous and lymphatic diseases. Outcome reports (e.g. risk-factor distribution, indications, patency rates, and complication rates) will be available in real time and physicians will have the ability to compare them with the aggregated outcomes of all entries in the database. The Registry can be programmed to generate lists for pending follow-ups, letters to patients, and reminder emails to physicians.
The Registry is web-based and allows the individual clinician to enter patient information into the database from the hospital, an office-based practice, or even from home. Clinicians can add as many cases as they wish and where possible they will be encouraged to put on retrospective data (if available).
“We are thrilled to be part of this exciting project. The registry is the largest database of its kind specifically designed for venous and lymphatic disease and will be of tremendous educational value to the AVLS, its members and ultimately, patients,” said Dr Peter Walton, Managing Director of Dendrite Clinical Systems. “The Registry represents an important milestone for the company and reflects our expanding database portfolio.”
